Superworth

Oric Pharmaceuticals price to book ratio ORIC

Market value divided by the book value of the company's net assets, since 2020.

Today, Nov 2, 2026
2.5×
6-year median
2.2×
Against its 6-year history
57th
percentile: 0 is its lowest day, 100 its highest
6-year range
0.4× to 6.7×
Peer median
2.7×

Oric Pharmaceuticals' price to book ratio is 2.5× as of Nov 2, 2026.

That is above its 6-year median of 2.2×, close to the middle of its last 6 years.

Over that time it ranged from 0.4× in Nov 2022 to 6.7× in Dec 2020.

The median for 10 large drugmakers of a similar size is 2.7×.

Price to book ratio over time

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far2.5×1.9×3.9×
20252.0×1.4×4.1×
20242.1×1.5×4.5×
20232.0×0.8×2.1×
20221.1×0.4×1.9×
20212.0×1.9×6.0×
20205.7×3.0×6.7×

Against its peers

Companies in Drug Manufacturers - General nearest Oric Pharmaceuticals' size, closest first, today.

What the price to book ratio tells you

Market value divided by the accounting value of the company's net assets. Below 1 means the market values the business at less than what it owns on paper.

Book value misses brands, software and people, so asset-light companies always look expensive on it. Most useful for banks and industrials.

More on Oric Pharmaceuticals

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.